Nicholas Baxter - Oct 12, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Stock symbol
LEXX
Transactions as of
Oct 12, 2022
Transactions value $
$0
Form type
4
Date filed
10/13/2022, 12:49 PM
Previous filing
Mar 8, 2022
Next filing
Jul 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11K Oct 12, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +18.2K +154.24% $0.00 30K Oct 12, 2022 Common Shares 18.2K $1.96 Direct
holding LEXX Stock Options 1.5K Oct 12, 2022 Common Shares 1.5K $5.31 Direct
holding LEXX Stock Options 6.5K Oct 12, 2022 Common Shares 5K $7.08 Direct
holding LEXX Stock Options 8.4K Oct 12, 2022 Common Shares 1.9K $6.23 Direct
holding LEXX Stock Options 11.8K Oct 12, 2022 Common Shares 3.4K $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.